Pharma & Biotech

The investment narrative surrounding transplant diagnostics firm CareDx is one of stark contrasts. The company’s latest quarterly results revealed significant...

While Electrocore's stock has experienced significant downward pressure in recent months, a notable consensus persists among market analysts. All eight...

Shares of clinical-stage biopharmaceutical company IO Biotech concluded Friday's trading session unchanged at $1.58, following a volatile period that saw...

Aldeyra Therapeutics has announced significant regulatory progress for its two leading pharmaceutical candidates, ADX-2191 and reproxalap. These developments position the...

While Curis shares closed flat at $1.67 in recent trading, market experts continue to express confidence in the biotechnology firm's...

Jazz Pharmaceuticals has achieved two significant regulatory milestones for its oncology therapeutic, Modeyso. The company obtained both an accelerated approval...

Biotech firm Akari Therapeutics finds itself navigating a severe financial crisis, marked by the abrupt departure of its chief financial...

Celularity Inc. finds itself navigating a critical period as it confronts potential delisting from the Nasdaq exchange. The biotechnology company...

The biotechnology firm Atara Biotherapeutics stands at a pivotal juncture. Following significant regulatory progress and unexpectedly strong quarterly earnings, the...

Eli Lilly stands poised to revolutionize obesity treatment with its experimental oral medication Orforglipron, following outstanding Phase 3 clinical trial...